Arteris 2025 Q3 Earnings Revenue Surges 18.3% Despite 17% Wider Net Loss

Wednesday, Nov 5, 2025 4:56 am ET1min read
AIP--
Aime RobotAime Summary

- ArterisAIP-- (AIP) reported 18.3% Q3 revenue growth to $17.41M, driven by AI/SoC demand, but net loss widened 17% to $1.2M.

- Licensing/support revenue ($15.9M) and variable royalties ($1.5M) highlighted strong traction in high-growth markets.

- CEO Janac emphasized strategic wins with Altera/AMD and expanded AlibabaBABA-- collaboration, while raising 2025 guidance cautiously.

- Post-earnings stock dropped 9.74% weekly, reflecting mixed investor sentiment between growth optimism and profit concerns.

- Company received Gold Stevie Award for innovation and maintained cautious liquidity guidance amid five-quarter losses.

Arteris (AIP) reported fiscal 2025 Q3 earnings on November 4, 2025, delivering revenue growth that exceeded expectations while posting a wider-than-expected net loss. The company raised full-year guidance slightly but maintained caution on profitability, reflecting ongoing financial challenges.

Revenue

. Licensing and support revenue accounted for the majority of this growth, with $15.90 million generated from fixed-fee contracts. Variable royalties and other revenue also contributed significantly, totaling $1.51 million, driven by expanding AI adoption and chiplet/SoC demand. Notably, variable royalties alone reached $1.50 million, underscoring the company’s traction in high-growth markets.


Earnings/Net Income

The company’s losses deepened in Q3 2025, , . , sustained losses over five consecutive quarters highlight structural challenges. The EPS decline, though modest, reflects persistent operational inefficiencies.


Post-Earnings Price Action Review


, with a steeper 9.74% drop over the preceding week, . The post-earnings performance suggests mixed investor sentiment: while short-term volatility reflects concerns over profitability, the MTD rally indicates optimism about the company’s long-term growth prospects in AI and autonomous driving. .


CEO Commentary

CEO highlighted record ACV and RPO figures, . Key wins included Altera’s adoption of ArterisAIP-- IP for FPGA/SoC designs and AMD’s incremental FlexGen licenses. Janac emphasized investments in ecosystem collaborations (e.g., Alibaba, UALink) and product innovation (FlexGen, Magillem) to address advanced node requirements.


Guidance

. , , signaling cautious optimism about liquidity management.


Additional News

Arteris secured high-profile partnerships in Q3 2025, including Altera’s licensing of its FlexGen and Ncore IP for next-generation FPGA/SoC development. The company also expanded its collaboration with Alibaba DAMO Academy to optimize RISC-V SoC designs for edge AI and automotive applications. Additionally, Arteris was recognized with a Gold Stevie® Award for Most Innovative Tech Company of the Year, underscoring its leadership in semiconductor IP innovation.


Image



Article Polishing

Transitions between sections have been refined for clarity and flow. Punctuation and spacing were standardized to enhance readability. Numerical data and factual details remain unchanged, preserving the original structure and emphasis on Arteris’ strategic and financial developments.

Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet